BAC
Bank of America Corporation
BAC has the edge over GLRE overall, supported by stronger valuation and stronger fundamentals.
GLRE
Greenlight Capital Re, Ltd.
GLRE trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
GLRE Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| N/A | |
| N/A |
GLRE's profitability is currently healthy, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like GLRE.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over GLRE in the historical PE scenario, which offers more potential upside but is not a forecast.
GLRE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.1x | $8.62 | -47% |
| Fair | 7.5x | $12.69 | -22% |
| Current | 9.7x | $16.36 | — |
| Expensive | 15x | $25.44 | +56% |
Historical ranges are pointers, not guarantees.
GLRE's PE is in its fair range at 9.7x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
GLRE Forward outlook
There aren't enough analyst estimates for GLRE to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over GLRE on earnings, with more consistent year-over-year improvement.
GLRE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.69 | +$1.73 |
| Q2 2026 | $1.46 | +33% |
| Q1 2026 | $2.36 | +79% |
| Q4 2025 | $2.17 | +75% |
| Q3 2025 | -$0.04 | -102% |
| Q2 2025 | $1.10 | -46% |
| Q1 2025 | $1.32 | -58% |
| Q4 2024 | $1.24 | -50% |
GLRE has returned to profit: it earned $1.69 per share over the past year, after losing money the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over GLRE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
GLRE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $148.3M | +1.5% |
| Q2 2026 | $137.5M | -14% |
| Q1 2026 | $189.7M | -11% |
| Q4 2025 | $210.3M | +48% |
| Q3 2025 | $146.1M | -22% |
| Q2 2025 | $160.1M | -8.4% |
| Q1 2025 | $213.3M | +11% |
| Q4 2024 | $141.8M | -8.8% |
GLRE's revenue fell from its 2025 peak and has held roughly level since: $148M last quarter, up 1.5% from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
GLRE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.9M | -84% |
| Q2 2026 | $31.4M | -54% |
| Q1 2026 | $37.2M | +259% |
| Q4 2025 | $100.2M | +239% |
| Q3 2025 | $31.2M | -25% |
| Q2 2025 | $68.4M | +201% |
| Q1 2025 | $10.4M | -42% |
| Q4 2024 | $29.5M | +33% |
GLRE's free cash flow was $174M over the past year, up 25% from the year before. Free cash flow isn't a meaningful measure for financial services companies like GLRE.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over GLRE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
GLRE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +104K shares |
| 1 year | -1.6% | -548K shares |
| 3 years | -4.6% | -1.6M shares |
| 5 years | +0.9% | +283K shares |
| Available history | -8.1% | -2.9M shares |
GLRE has 33M diluted shares, down 1.6% from a year ago, with $30M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $8M |
| Q2 2026 | $14.2M |
| Q1 2026 | $5M |
| Q4 2025 | $2.8M |
| Q3 2025 | $2M |
| Q4 2024 | — |
| Q3 2024 | $7.5M |
| Q4 2023 | — |
GLRE spent $30M buying back its own shares over the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
GLRE Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
GLRE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.0 | Neutral |
| Stochastic | 52.0 | Neutral |
GLRE's weekly RSI is 58 (neutral) and its Stochastic is 52 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
GLRE PE vs Financial Services Sector
| Metric | GLRE | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 13x | 26% below |
| PE % | 58 | 63 | 5 pts below |
GLRE has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
GLRE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.2 | 7.8% above |
| 20 week MA | $15.6 | 4.7% above |
| 50 week MA | $15.6 | 4.7% above |
| 100 week MA | $14.5 | 13% above |
| 200 week MA | $13.1 | 25% above |
GLRE has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
GLRE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.1 | $7.16 | -29% |
| 2021 | $7.16 | $7.40 | +3.4% |
| 2022 | $7.40 | $8.09 | +9.3% |
| 2023 | $8.09 | $11.4 | +41% |
| 2024 | $11.4 | $13.8 | +21% |
| 2025 | $13.8 | $14.4 | +4.3% |
| 2026 YTD | $14.4 | $16.4 | +13% |
GLRE has the edge over BAC on returns for 2026, with the stronger performance.